A strategic approach to developing and commercialising medical devices is becoming ever more valuable. Not only are many regulatory, quality and clinical milestones significant value inflection points for any company or project, but their long-term success depends on a clear strategic approach to what has become a complex regulatory world. And that approach needs to be tailored bespoke for each business need.
With this in mind, Psephos Biomedica is pleased to announce a significant new member of the Psephos network: Linnea Aasen-Johnson of Bespoke Business Solutions, Canada.
Linnea has more than 10 years of experience in medical device research with executive level experience in Fortune 500 companies as well as serving innovative start-ups.
Linnea’s strengths include being able to provide clients with perspective from corporate stakeholders as well as ‘voice of the customer’ to help create and execute the clinical projects that yield best return for clients’ long-term outcomes.
Her skill set brings not only pre-commercial clinical expertise, but clinical marketing and training abilities too.
Linnea’s main focus is on the growing Canadian marketplace, but her strategic clinical insights will add to the Psephos network pool of resources that continue to bring best practice to services for our clients.
For more information on Bespoke Business Solutions: www.bespokebusinesssolutions.ca
Contact Psephos for more information on our services or if you are interested in working with us: email@example.com